Literature DB >> 31010812

CD4+ T Cell Regulation of Antibodies Cross-Reactive with Fungal Cell Wall-Associated Carbohydrates after Pneumocystis murina Infection.

Rekha R Rapaka1, Guixiang Dai2, Mingquan Zheng2, Jay K Kolls2.   

Abstract

Pneumocystis pneumonia is a life-threatening opportunistic fungal infection observed in individuals with severe immunodeficiencies, such as AIDS. Molecules with the ability to bind β-glucan and signal at Fcγ receptors enhance defense against Pneumocystis f. sp. murina, though it is unclear whether antibodies reactive with fungal cell wall carbohydrates are induced during Pneumocystis infection. We observed that systemic and lung mucosal immunoglobulins cross-reactive with β-glucan and chitosan/chitin are generated after Pneumocystis infection, with increased quantities within the lung mucosal fluid after challenge. While IgG responses against Pneumocystis protein antigens are markedly CD4+ T cell dependent, CD4+ T cell depletion did not impact quantities of IgG cross-reactive with β-glucan or chitosan/chitin in the serum or mucosa after challenge. Notably, lung mucosal quantities of IgA cross-reactive with β-glucan or chitosan/chitin are decreased in the setting of CD4+ T cell deficiency, occurring in the setting of concurrent reduced quantities of active transforming growth factor β, while mucosal IgM is significantly increased in the setting of CD4+ T cell deficiency. Interleukin-21 receptor deficiency does not lead to reduction in mucosal IgA reactive with fungal carbohydrate antigens after Pneumocystis challenge. These studies demonstrate differential CD4+ T cell-dependent regulation of mucosal antibody responses against β-glucan and chitosan/chitin after Pneumocystis challenge, suggesting that different B cell subsets may be responsible for the generation of these antibody responses, and suggest a potential immune response against fungi that may be operative in the setting of CD4+ T cell-related immunodeficiency.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  CD4 T cell; Pneumocystiszzm321990; antibody; beta glucan; chitin; infectious disease; mucosal immunity; opportunistic fungi

Mesh:

Substances:

Year:  2019        PMID: 31010812      PMCID: PMC6589063          DOI: 10.1128/IAI.00158-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Chitinases in Pneumocystis carinii pneumonia.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Med Microbiol Immunol       Date:  2012-04-26       Impact factor: 3.402

Review 2.  The cell wall: a carbohydrate armour for the fungal cell.

Authors:  Jean-Paul Latgé
Journal:  Mol Microbiol       Date:  2007-09-14       Impact factor: 3.501

3.  Characterization of N-Acetylglucosamine Biosynthesis in Pneumocystis species. A New Potential Target for Therapy.

Authors:  Theodore J Kottom; Deanne M Hebrink; Paige E Jenson; Jorge H Ramirez-Prado; Andrew H Limper
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

4.  CD4+ T cell-independent DNA vaccination against opportunistic infections.

Authors:  Mingquan Zheng; Alistair J Ramsay; Myles B Robichaux; Corrine Kliment; Christopher Crowe; Rekha R Rapaka; Chad Steele; Florencia McAllister; Judd E Shellito; Luis Marrero; Paul Schwarzenberger; Qiu Zhong; Jay K Kolls
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

5.  Light and electron microscopy study of carbohydrate antigens found in the electron-lucent layer of Pneumocystis carinii cysts.

Authors:  A Roth; J Wecke; V Karsten; K Janitschke
Journal:  Parasitol Res       Date:  1997       Impact factor: 2.289

6.  IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells.

Authors:  J K Kolls; S Habetz; M K Shean; C Vazquez; J A Brown; D Lei; P Schwarzenberger; P Ye; S Nelson; W R Summer; J E Shellito
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

7.  Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein.

Authors:  Rekha R Rapaka; Eric S Goetzman; Mingquan Zheng; Jerry Vockley; Laura McKinley; Jay K Kolls; Chad Steele
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

8.  Beta-glucan-CRM197 conjugates as candidates antifungal vaccines.

Authors:  Carla Bromuro; Maria Romano; Paola Chiani; Francesco Berti; Marta Tontini; Daniela Proietti; Elena Mori; Antonella Torosantucci; Paolo Costantino; Rino Rappuoli; Antonio Cassone
Journal:  Vaccine       Date:  2010-01-21       Impact factor: 3.641

9.  Dual role for B-1a cells in immunity to influenza virus infection.

Authors:  Youn Soo Choi; Nicole Baumgarth
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

10.  Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor.

Authors:  Chad Steele; Luis Marrero; Steve Swain; Allen G Harmsen; Mingquan Zheng; Gordon D Brown; Siamon Gordon; Judd E Shellito; Jay K Kolls
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more
  1 in total

1.  Germline IgM predicts T cell immunity to Pneumocystis.

Authors:  Kristin Noell; Guixiang Dai; Dora Pungan; Anna Ebacher; Janet E McCombs; Samuel J Landry; Jay K Kolls
Journal:  JCI Insight       Date:  2022-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.